AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591
Cannabis Law Report
JUNE 4, 2021
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:
Let's personalize your content